Biogen's SWOT analysis: stock faces challenges amid pipeline potential By...

Published on 18 Feb 2025 on Investing.com

Biogen's SWOT analysis: stock faces challenges amid pipeline potential

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. I...

Insider Monkey · via Yahoo Finance 23 Feb 2025

Biogen Inc.'s (NASDAQ:BIIB) recent earnings report didn't offer any surprises, with the shares...

Simply Wall St. · via Yahoo Finance 19 Feb 2025

On Tuesday, Biogen Inc. (NASDAQ:BIIB) and Stoke Therapeutics, Inc. (NASDAQ:STOK) collaborated to...

Benzinga · via Yahoo Finance 18 Feb 2025

Biogen's SWOT analysis: stock faces challenges amid pipeline potential

Investing.com 18 Feb 2025

Biogen's SWOT analysis: stock faces challenges amid pipeline potential

Investing.com 18 Feb 2025

Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the compa...

The Business Journals 12 Feb 2025

Biogen Inc. (NASDAQ:BIIB), currently valued at $19.15 billion by market capitalization, reported ...

Investing.com 12 Feb 2025

We recently published a list of Jim Cramer’s Thoughts on These 7 Stocks. In this article, we are...

Insider Monkey · via Yahoo Finance 1 Feb 2025

Biogen (BIIB) has an impressive earnings surprise history and currently possesses the right...

Zacks · via Yahoo Finance 29 Jan 2025

Sage Therapeutics turns down Biogen's offer to buy the remaining stake in the company and is...

Zacks · via Yahoo Finance 28 Jan 2025